AMA Interim Meeting Advances Policies for Patient Safety and Public Health

<p>The AMA Interim Meeting convened in Orlando from November 9–10, 2026, to address current public health and patient protection issues. During this meeting, the House of Delegates adopted multiple new policies that seek to better safeguard patients and communities.</p><p>Notable policy areas include actions on unapproved synthetic peptides, steps ...

Published date: 11-11-2026 11:01 AM

Source:

The AMA Interim Meeting convened in Orlando from November 9–10, 2026, to address current public health and patient protection issues. During this meeting, the House of Delegates adopted multiple new policies that seek to better safeguard patients and communities.

Notable policy areas include actions on unapproved synthetic peptides, steps to modernize sunscreen regulations, and approaches aimed at preventing lung disease in workers—a critical occupational health concern.

These adopted measures reflect the AMA’s continued commitment to support healthcare professionals with updated guidance and public health strategies.

The American Medical Association (AMA) held its Interim Meeting on November 9–10, 2026, in Orlando, where the House of Delegates approved several new policies.

These policies focus on protecting patients and strengthening public health efforts. Key areas addressed include regulation of unapproved synthetic peptides, modernization of sunscreen standards, and prevention of lung disease among workers.

This official action by the AMA is significant for physicians and healthcare professionals committed to advancing patient safety and public health initiatives.

View Comments (0)

Want to join the conversation?

Already a member? Login New to JobsReach Healthcare? Sign up